Avrion Therapeutics AG
PrivateLast Round
Seed
Jun 1, 2021
Total Funding Raised
$2.42M
Company Overview
Avrion Therapeutics AG operates in Healthcare & Life Sciences and is based in Lausanne. Its latest recorded funding round was a Seed round in June 2021.
Avrion Therapeutics AG is a biotechnology company that develops precision gene therapy solutions for genetically defined neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avrion Therapeutics AG Comparables
Compare Avrion Therapeutics AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Celosia Therapeutics | 88% | |
| SineuGene Therapeutics | 85% | |
| Capsida Biotherapeutics | 81% |
For institutional investors. Book with your work email.
Avrion Therapeutics AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 1, 2021 | ||||
| Grant | Jun 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Avrion Therapeutics AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innosuisse | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2021
$1.1M round with Gaël Hédou participating.
For institutional investors. Book with your work email.
Avrion Therapeutics AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Avrion Therapeutics AG's valuation, stock price, and market status.
Is Avrion Therapeutics AG a public or private company?
Avrion Therapeutics AG is a private company.
What is the current stock price of Avrion Therapeutics AG?
Avrion Therapeutics AG is a private company, so its shares have no public market price. Caplight tracks Avrion Therapeutics AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Avrion Therapeutics AG worth (valuation)?
Valuation information for Avrion Therapeutics AG is not publicly available.
Can I buy Avrion Therapeutics AG stock?
Avrion Therapeutics AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Avrion Therapeutics AG's last funding round?
Avrion Therapeutics AG's most recent funding round was Seed on June 1, 2021.
Who are the main investors in Avrion Therapeutics AG?
Key investors in Avrion Therapeutics AG include Innosuisse.
Will Avrion Therapeutics AG IPO soon?
No public IPO plans have been announced for Avrion Therapeutics AG.
How can I track Avrion Therapeutics AG secondary market activity?
Caplight tracks bids, offers, and trades in Avrion Therapeutics AG's shares on secondary markets.